You can't "infer or imply" adaptive trials. Read the FDA Adaptive Trial Guidance -- the NWBO trial doesn't meet any of the requirements. The trial has to be designed as adaptive and approved BEFORE the trial starts as such -- NWBO certainly didn't do that. It requires and interim review and decision tree on adapting the trial -- NWBO certainly didn't do that. NWBO did all of the protocol changes AFTER the data gathering had been gathered.